Model
Edge
Moonlake Immunotherapeutics
0001920553
Filing Type
4
Filing Date
2/15/2024
Updated
2/16/24, 11:02 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership